期刊文献+

多民族呼吸道、消化道肿瘤凝血功能相关指标的临床对照研究

Clinical study of dysfunction of blood coagulation in patients of multiple nationalities with respiratory and digestive tract malignant tumors
下载PDF
导出
摘要 目的探讨呼吸道、消化道恶性肿瘤患者凝血功能相关指标的变化及不同部位肿瘤对凝血功能的影响。方法定量检测对照组(40例)、呼吸道肿瘤组(40例)、消化道肿瘤组(40例)患者的血小板(PLT)计数、血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、血浆纤维蛋白原(FIB)和D-二聚体(D-D)含量并进行对比分析,同时进行组间差异性比较。结果呼吸道肿瘤组PLT、PT、APTT、TT、FIB及D-D含量均高于正常对照组,消化道肿瘤组PT、FIB、APTT及D-D含量高于对照组,呼吸道肿瘤组FIB高于消化道肿瘤组,差异均有统计学意义(P<0.05)。结论呼吸道及消化道恶性实体瘤患者均存在明显的凝血功能异常;恶性实体瘤凝血功能异常可能与肿瘤的原发部位无关,与肿瘤细胞自身对凝血系统的影响有关。 Objective To study the level of blood clotting indexes in respiratory and digestive tract malignant tumors,and to investigate the influence in different locations.Methods The levels of platelet count(PLT),prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT),plasmatic fibrinogen(FIB) and D-dimmer content(D-D) were tested in the blood samples in 40 respiratory tumor patients(respiratory tumor group),40 digestive tract tumor patients(digestive tract tumor group) and 40 healthy people(control group),analyzed the differences among those groups.Results: The levels of plasma PLT,PT,APTT,TT,FIB and D-D in respiratory tumor group were significantly higher than the control group(P0.05).The levels of plasma PT,FIB,APTT and D-D in digestive tract tumor group were significantly higher than the control group(P0.05).The levels of plasma FIB in respiratory tumor group were significantly higher than the digestive tract patients(P0.05).Conclusion Respiratory and digestive tract malignant tumor patients were abviously manifested abnormal in coagulant function.There seemes no ralationship between the abnormality in coagulant function and the primary location of the malignant tumors.Malignant tumor patients may irrelevate with tumor primary site.
出处 《新疆医科大学学报》 CAS 2012年第10期1333-1336,共4页 Journal of Xinjiang Medical University
关键词 呼吸道 消化道 恶性肿瘤 凝血功能异常 respiratory gastrointestinal malignant tumor dysfunction of coagulation
  • 相关文献

参考文献17

  • 1Sud R, Khorana AA. Cancer-associated thrombosis: risk fac- tors, candidate biomarkers and a risk model[J]. Thromb Res, 2009, 123(Suppl 4):S18-21.
  • 2Khorana AA, Francis CW, Culakova E, et al. Thromboembo lism is a leading cause of death in cancer patients receiving out patient chemotherapy[J]. J Thromb Haemost, 2007, 5(3): 632-634.
  • 3Lopez JA, Chen J. Pathophysiology of venous thrombosis[J]. Thromb Res, 2009, 123 (Suppl 4):S30-34.
  • 4Wun T, White RH. Venous thromboembolism (VTE) in pa tients with cancer: epidemiology and risk factors[J]. Cancer Invest, 2009, 27(Suppl 1) :63 -74.
  • 5Monreal M, Trujillo-Santos J. Screening for occult cancer in patients with acute venous thromboembolism[J]. Curr Opin Pulm Med, 2007, 13(5) :368-371.
  • 6Haddad TC, Greeno EW. Chemotherapy induced thrombosis [J]. Thromb Res, 2006, 118(5):555-568.
  • 7Caine GJ, Lip GY, Zanetto U, et al. A comparison of plasma versus histologic indices of angiogenic markers in breast cancer [J]. Appl Immunohistochem Mol Morphol, 2007, 15(4) :382- 388.
  • 8Caine GJ, Stonelake PS, Lip GY, et al. Changes in plasma vascular endothelial growth factor, angiopoietins, and their re- ceptors following surgery for breast cancer[J]. Cancer Lett, 2007, 248(1):131-136.
  • 9Yokota N, Koizume S, Miyagi E, et al. Selfproduction of tis sue factor-coagulation factor Ⅶ complex by ovarian cancer cells[J]. BrJ Cancer, 2009, 101(12),2023- 2029.
  • 10Bluff JE, Brown NJ, Reed MW, et al. Tissue factor, anio genesis and tumor progression[J]. Breast Cancer Res, 2008, 10(2) :204 .

二级参考文献10

  • 1Eckman NH, Levine HI, Pauker SG. Effect of labora-tory variation in the prothrombin Time ratio on the resuits of oral anticoagulant therapy. N Engl J Med, 1993 ;329:696 - 702.
  • 2Melegary M, Scaglioni PP, Mao GP, et al. Medicine ( Firenze). 1990 ; 10 : 154 - 157.
  • 3Williamson D, Brown K, Laddington R, et al. Factor V cambrige:a new mutation association with resistance to activated protein C. Blood, 1998 ; 91 : 1140 - 1144.
  • 4Martine ZJ, Quantitative and qualititafive disorders of fibrinogen. In: Hoffan R, Beng E J, Shattit S J, et al. eds. Heamtology Basic Principles and practice. 2nded. New York: Churchill Livingstone inc, 1995; 1703 - 1707.
  • 5Laheenmarki P, Pasi V, Lakkainen T. Coagulantion factors in women using oval contraeeptiyes devices immediately after abortion. AM J Obstet, 1981 ; 141 : 175.
  • 6王振义.外科手术中的出血与血栓形成.第2版.上海:上海科学技术出版社,1996.
  • 7[2]John CP,Barbara,O'Brien.Early Pregnancy Loss eMedicine Journal,November 21 2001,Volume 2,Number 11 c.Copyright,2002,eMedicine.com.
  • 8周道银,易滨,石磊,吕雁群.纤维结合蛋白、纤维蛋白原及凝血酶原时间在肝硬化、肝癌中的意义[J].临床肝胆病杂志,1998,14(4):224-226. 被引量:14
  • 9顾健,顾惠心,罗金凤.妊娠期性激素水平对血栓前状态作用[J].实用临床医药杂志,1997,6(6):407-412. 被引量:2
  • 10丁虹,朱付凡.妊娠期血液高凝状态与产科并发症[J].中华妇产科杂志,2003,38(10):643-646. 被引量:56

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部